Original article
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
Takanori Suzukia, Akihiro Tamorib,c, Kentaro Matsuuraa,
, Takako Inoued, Shigeru Kusumotoe,f, Shinya Hagiwarae,f, Haruka Sagig, Atsushi Kanekog, Shuko Murakamih, Hayato Kawamraa, Kei Fujiwaraa, Katsumi Aoyagig,i, Masaru Enomotob, Ritsuzo Kozukab, Hiromi Kataokaa, Yasuhito Tanakaj
Corresponding author
a Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
b Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
c Department of Hepatology, Kashiwara Municipal Hospital, Kashiwara, Japan
d Department of Clinical Laboratory Medicine, Nagoya City University Hospital, Nagoya, Japan
e Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
f Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
g Fujirebio Inc., Hachioji, Tokyo, Japan
h Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
i Advanced Life Science Institute, Inc., Hachioji, Tokyo, Japan
j Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
Ver másRead
3198
Timeswas read the article
2267
Total PDF
931
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 33 | 84 | 117 |
| 2025 11 | 112 | 555 | 667 |
| 2025 10 | 92 | 454 | 546 |
| 2025 9 | 68 | 431 | 499 |
| 2025 8 | 111 | 354 | 465 |
| 2025 7 | 162 | 233 | 395 |
| 2025 6 | 68 | 31 | 99 |
| 2025 5 | 39 | 49 | 88 |
| 2025 4 | 36 | 31 | 67 |
| 2025 3 | 44 | 11 | 55 |
| 2025 2 | 63 | 6 | 69 |
| 2025 1 | 52 | 5 | 57 |
| 2024 12 | 51 | 23 | 74 |
Show all
